Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Non-Interventional Study To Evaluate Diabetes Related Quality Of Life, Frequency And Impact Of Hypoglycemia In Type 2 Diabetes Patients On Pharmacotherapy (INSIGHT)

NCT01523405 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT01523405
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01523405 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Non-Interventional Study To Evaluate Diabetes Related Quality Of Life, Frequency And Impact Of Hypoglycemia In Type 2 Diabetes Patients On Pharmacotherapy (INSIGHT)
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
March 31, 2012
Completion date
February 28, 2013
Enrollment
4,911 (actual)
Sites
70

Conditions

As the registry lists them; a condition with its own page is linked.

type ii diabetes mellitus